Stock PTG POLTREG S.A.
Add to a list
To use this feature you must be a member
Log inSign up

All News Poltreg S.A.

Equities

PTG

PLPLTRG00038

Market Closed - Warsaw S.E.
Other stock markets
 11:55:46 2024-07-16 am EDT 		5-day change 1st Jan Change
49.1 PLN -4.84% Intraday chart for Poltreg S.A. -2.19% -1.41%
Jun. 24 PolTREG?s Type-1 Diabetes Treg Cell Therapy PTG-007 Demonstrates Long-Term Safety and Efficacy for Up to 12 Years CI
May. 23 Poltreg S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for up to 12 years
AQ
PolTREG?s Type-1 Diabetes Treg Cell Therapy PTG-007 Demonstrates Long-Term Safety and Efficacy for Up to 12 Years
CI
Poltreg S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Poltreg S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
PolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with its Treg therapy in combination with rituximab
AQ
PolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing site in Poland
AQ
Poltreg S.A. Receives CGMP Certification to Produce Cell Therapies At Its State-Of-The-Art Manufacturing Site in Poland
CI
PolTREG appoints Dan Shelly as Chief Business Development Officer
AQ
PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoimmune therapy
AQ
PolTREG receives US Patent Office Notice of Allowance for Treg cell therapy to treat Type-1 Diabetes
AQ
Poltreg S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Poltreg S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Poltreg S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Poltreg S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Poltreg S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Poltreg S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Poltreg S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Poltreg S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Poltreg S.A. has completed an IPO in the amount of PLN 125.086575 million.
CI
Poltreg S.A. has filed an IPO in the amount of PLN 130 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTG Stock
  4. News Poltreg S.A.